Assertio Historical Balance Sheet

ASRT Stock  USD 0.96  0.04  4.00%   
Trend analysis of Assertio Therapeutics balance sheet accounts such as Short Long Term Debt Total of 38.9 M, Other Current Liabilities of 83 M or Total Current Liabilities of 72.3 M provides information on Assertio Therapeutics' total assets, liabilities, and equity, which is the actual value of Assertio Therapeutics to its prevalent stockholders. By breaking down trends over time using Assertio Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Assertio Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Assertio Therapeutics is a good buy for the upcoming year.

Assertio Therapeutics Inventory

39.57 Million

  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assertio Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Assertio Stock please use our How to Invest in Assertio Therapeutics guide.

About Assertio Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Assertio Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Assertio Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Assertio Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Assertio currently owns. An asset can also be divided into two categories, current and non-current.

Assertio Therapeutics Balance Sheet Chart

At this time, Assertio Therapeutics' Total Liabilities is comparatively stable compared to the past year. Cash is likely to gain to about 80.2 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 93.7 M in 2024.

Total Assets

Total assets refers to the total amount of Assertio Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Assertio Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Assertio Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Assertio Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Most accounts from Assertio Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Assertio Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assertio Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Assertio Stock please use our How to Invest in Assertio Therapeutics guide.At this time, Assertio Therapeutics' Total Liabilities is comparatively stable compared to the past year. Cash is likely to gain to about 80.2 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 93.7 M in 2024.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total73.5M66.9M40.9M38.9M
Total Assets326.5M413.9M286.4M336.5M

Assertio Therapeutics balance sheet Correlations

0.91-0.730.790.750.880.730.30.60.940.210.83-0.250.280.980.60.850.440.420.98-0.290.480.55-0.130.960.87
0.91-0.920.710.590.870.790.420.670.910.30.77-0.40.070.910.40.930.260.250.93-0.430.650.63-0.190.950.86
-0.73-0.92-0.5-0.49-0.68-0.67-0.43-0.8-0.75-0.3-0.620.340.11-0.74-0.29-0.93-0.18-0.18-0.760.42-0.75-0.540.18-0.82-0.68
0.790.71-0.50.310.650.77-0.10.340.850.420.88-0.10.260.850.20.550.040.00.79-0.040.10.320.070.770.65
0.750.59-0.490.310.610.220.390.570.52-0.170.54-0.060.170.60.860.710.760.760.65-0.220.620.5-0.130.630.57
0.880.87-0.680.650.610.640.460.450.820.110.64-0.450.210.880.540.760.420.40.91-0.520.480.69-0.190.850.99
0.730.79-0.670.770.220.640.050.380.910.680.73-0.230.350.82-0.080.59-0.25-0.270.8-0.090.130.2-0.160.860.65
0.30.42-0.43-0.10.390.460.050.290.17-0.38-0.07-0.85-0.370.250.440.470.490.510.37-0.930.640.66-0.150.320.5
0.60.67-0.80.340.570.450.380.290.540.250.42-0.14-0.020.560.420.770.360.360.58-0.220.720.37-0.020.620.45
0.940.91-0.750.850.520.820.910.170.540.470.84-0.220.330.970.280.760.110.080.96-0.190.320.4-0.110.960.82
0.210.3-0.30.42-0.170.110.68-0.380.250.470.310.130.580.3-0.510.14-0.62-0.650.260.39-0.19-0.420.080.330.13
0.830.77-0.620.880.540.640.73-0.070.420.840.310.050.220.830.340.710.150.110.79-0.010.270.370.010.830.63
-0.25-0.40.34-0.1-0.06-0.45-0.23-0.85-0.14-0.220.130.050.26-0.28-0.18-0.34-0.21-0.22-0.370.89-0.4-0.530.03-0.33-0.52
0.280.070.110.260.170.210.35-0.37-0.020.330.580.220.260.290.01-0.01-0.1-0.130.260.5-0.34-0.430.170.230.21
0.980.91-0.740.850.60.880.820.250.560.970.30.83-0.280.290.460.810.310.280.99-0.280.390.51-0.120.970.87
0.60.4-0.290.20.860.54-0.080.440.420.28-0.510.34-0.180.010.460.570.970.970.51-0.350.590.59-0.110.430.51
0.850.93-0.930.550.710.760.590.470.770.760.140.71-0.34-0.010.810.570.460.450.84-0.420.790.59-0.160.870.75
0.440.26-0.180.040.760.42-0.250.490.360.11-0.620.15-0.21-0.10.310.970.460.990.36-0.40.550.55-0.10.280.4
0.420.25-0.180.00.760.4-0.270.510.360.08-0.650.11-0.22-0.130.280.970.450.990.33-0.40.590.57-0.120.250.37
0.980.93-0.760.790.650.910.80.370.580.960.260.79-0.370.260.990.510.840.360.33-0.370.450.55-0.140.970.9
-0.29-0.430.42-0.04-0.22-0.52-0.09-0.93-0.22-0.190.39-0.010.890.5-0.28-0.35-0.42-0.4-0.4-0.37-0.56-0.770.12-0.32-0.57
0.480.65-0.750.10.620.480.130.640.720.32-0.190.27-0.4-0.340.390.590.790.550.590.45-0.560.72-0.170.480.47
0.550.63-0.540.320.50.690.20.660.370.4-0.420.37-0.53-0.430.510.590.590.550.570.55-0.770.72-0.220.520.68
-0.13-0.190.180.07-0.13-0.19-0.16-0.15-0.02-0.110.080.010.030.17-0.12-0.11-0.16-0.1-0.12-0.140.12-0.17-0.22-0.2-0.08
0.960.95-0.820.770.630.850.860.320.620.960.330.83-0.330.230.970.430.870.280.250.97-0.320.480.52-0.20.85
0.870.86-0.680.650.570.990.650.50.450.820.130.63-0.520.210.870.510.750.40.370.9-0.570.470.68-0.080.85
Click cells to compare fundamentals

Assertio Therapeutics Account Relationship Matchups

Assertio Therapeutics balance sheet Accounts

201920202021202220232024 (projected)
Total Assets527.2M303.3M326.5M413.9M286.4M336.5M
Short Long Term Debt Total351.3M84.1M73.5M66.9M40.9M38.9M
Other Current Liab2.1M103.3M114.2M88.5M79.1M83.0M
Total Current Liabilities184.6M132.7M135.0M95.3M93.4M72.3M
Total Stockholder Equity58.0M55.5M102.4M225.7M138.0M93.7M
Property Plant And Equipment Net3.5M2.4M1.5M744K2.0M1.9M
Net Debt309.2M63.3M36.7M1.9M(32.5M)(30.9M)
Retained Earnings(399.8M)(427.9M)(429.2M)(319.6M)(651.5M)(619.0M)
Accounts Payable16.2M14.8M6.7M6.0M13.4M15.6M
Non Current Assets Total423.2M209.0M223.0M281.7M115.4M203.4M
Non Currrent Assets Other6.1M4.9M5.5M2.4M2.0M2.1M
Net Receivables42.7M44.4M44.4M45.4M47.7M26.3M
Common Stock Shares Outstanding17.7M26.2M43.2M54.7M71.0M74.6M
Liabilities And Stockholders Equity527.2M303.3M326.5M413.9M286.4M336.5M
Other Current Assets15.7M34.8M29.7M16.5M24.2M25.5M
Total Liab469.2M247.8M224.1M188.2M148.4M242.8M
Total Current Assets104.0M94.3M103.5M132.3M171.1M133.1M
Short Term Debt80M14.6M14.2M871K928K881.6K
Cash42.1M20.8M36.8M64.9M73.4M80.2M
Cash And Short Term Investments42.1M20.8M36.8M64.9M73.4M95.5M
Non Current Liabilities Total284.7M115.1M89.1M92.9M55.0M52.2M
Other Stockholder Equity457.8M483.4M531.6M545.3M789.5M829.0M
Common Stock8K13K4K5K9K8.6K
Other Assets3.3M206.6M5.5M82.5M1.00.95
Long Term Debt271.3M72.2M61.3M66.4M38.2M36.3M
Property Plant Equipment3.5M4.8M1.5M881K1.0M962.5K
Current Deferred Revenue(2.4M)86.3M96.5M67.4M77.5M42.0M
Common Stock Total Equity313.9M6K8K13K11.7K11.1K
Property Plant And Equipment Gross3.5M2.4M1.5M744K6.7M5.7M
Other Liab8.6M40.1M27.8M26.5M23.8M29.7M
Inventory3.4M11.7M7.5M13.7M37.7M39.6M
Net Tangible Assets(342.6M)(144.6M)(113.6M)27.7M25.0M26.2M
Non Current Liabilities Other13.4M42.9M27.8M26.5M9.2M8.8M
Intangible Assets400.5M200.1M216.1M198.0M111.3M105.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Assertio Stock Analysis

When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.